ABOUT SGS QUAY PHARMA
Leading The Way In Microbiome Therapeutics
For over 20 years, SGS Quay Pharma has provided formulation development and clinical manufacturing services to the global pharmaceutical and biotech industries and has worked on over 200 projects.
We are known for our scientific creativity and innovation in development, as well as our flexibility and pragmatism for managing projects towards clinical trials, helping our customers overcome many scientific and technical challenges along the way.
This leading approach took us into the microbiome therapeutic space seven years ago and means that SGS Quay Pharma is the global leader in offering outsourced formulation development and clinical manufacture of dosage forms containing live bacterial strains.
Our commitment to this field is ongoing as we complete new GMP suites dedicated to taking microbiome therapeutic products into larger-scale Phase II and III trials and delivering new groundbreaking microbiome-based medicines to our customers.
Head of Microbiome Programme